Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Transplantation and Cellular Therapy|June 9, 2026
Monospecific and Bispecific Chimeric Antigen Receptor (CAR) T-Cell Therapy in Multiple Myeloma: A Systematic Review, Meta-analysis and Meta-regressionAinsley Ryan Yan Bin Lee, Hon Jen Wong, Chi Ching Lim, et al.
Research and Practice in Thrombosis and Haemostasis|December 11, 2023
Venous thromboembolism in an Asian COVID-19 cohort across 3 infection waves-a retrospective observational studyShir Ying Lee, Winnie Z Y Teo, Cheryl X Q Lim, et al.
Plos One|May 3, 2019
Atypical lymphocyte count correlates with the severity of dengue infectionChoong Shi Hui Clarice, Visula Abeysuriya, Sanjay de Mel, et al.
NPJ Digital Medicine|August 27, 2024
Personalized dose selection for the first Waldenström macroglobulinemia patient on the PRECISE CURATE.AI trialAgata Blasiak, Lester W J Tan, Li Ming Chong, et al.
Critical Reviews in Oncology/Hematology|October 17, 2021
Central nervous system (CNS) prophylaxis in antiCD20-CHOP treated DLBCL at intermediate to high risk for CNS relapse: A systematic review and meta-analysisGuiyi Ho, Cherie Tan, Sanjay de Mel, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 12, 2020
The atypical lymphocyte count: a novel predictive factor for severe thrombocytopenia related to dengueVisula Abeysuriya, Clarice Shi Hui Choong, Basuru Uvindu Thilakawardana, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 20, 2020
Triple positivity for nonstructural antigen 1, immunoglobulin M and immunoglobulin G is predictive of severe thrombocytopaenia related to dengue infectionSanjay de Mel, Basuru Uvindu Thilakawardana, Primesh de Mel, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|April 28, 2022
Postdischarge outcomes of COVID-19 patients from South Asia: a prospective studyVisula Abeysuriya, Suranjith L Seneviratne, Arjuna P De Silva, et al.
Leukemia & Lymphoma|December 16, 2025
Daratumumab bortezomib and dexamethasone in transplant ineligible newly diagnosed elderly myeloma patients (AMN006)-a trial by Asian Myeloma Network (NCT03695744)Melinda S Y Tan, Chandramouli Nagarajan, Melissa Ooi, et al.
Singapore Medical Journal|September 10, 2016
The Singapore Myeloma Study Group Consensus Guidelines for the management of patients with multiple myelomaSanjay de Mel, Yunxin Chen, Sathish Kumar Gopalakrishnan, et al.
Pageof 8